---
schema_version: "secwatch.filing_event.v1"
accession: "0001649094-25-000116"
form_type: "8-K"
ticker: "PCVX"
cik: "0001649094"
company_name: "Vaxcyte, Inc."
filed_at: "2025-12-19T23:59:59+00:00"
generated_at: "2026-05-16T12:35:02.342107+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Vaxcyte boosts severance multipliers for CEO Pickering and three other execs effective Dec 31, 2025

## Summary
- CEO Pickering: base salary severance multiplier for Qualifying Termination increases to 1.5x (from 1.0x); CIC termination to 2.0x (from 1.5x).
- CFO Guggenhime, COO Wassil, CTOO Dhaliwal: non-CIC multiplier rises to 1.0x (from 0.75x/0.5x); CIC to 1.5x (from 1.0x/0.75x).
- COBRA severance multipliers increased proportionally across all four executives.
- Changes effective Dec 31, 2025, approved by Compensation Committee to align with peer group levels.

## SEC filing metadata
- accession: 0001649094-25-000116
- form_type: 8-K
- ticker: PCVX
- cik: 0001649094
- company_name: Vaxcyte, Inc.
- filed_at: 2025-12-19T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1649094/000164909425000116/0001649094-25-000116-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1649094/000164909425000116/pcvx-20251218.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001649094-25-000116
- JSON: https://secwatch.observer/filing/0001649094-25-000116.json
- Plain text: https://secwatch.observer/filing/0001649094-25-000116.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.